Historical record - last NADAC effective date: 9/23/2020
Product Information
OMEPRAZOLE-BICARB 20-1,100 CAP is a generic product labeled by Oceanside Pharmaceuticals, priced at $1.4841 per EA under NDC 68682010230. Its NADAC has been published 302 times since Dec 9, 2015.
FDA first approved this application on Feb 27, 2006.
Strength
20; 1100 mg/1; mg/1
Manufacturer
Oceanside PharmaceuticalsNDC
68682010230
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2020
Active Ingredients
OMEPRAZOLE; SODIUM BICARBONATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021849FDA Approved
2/27/2006
On Market Since
2/27/2006
Pharmacological Classes
Price Statistics
The NADAC for OMEPRAZOLE-BICARB 20-1,100 CAP has been published 302 times since Dec 9, 2015, and over the history we have for it it has declined 86.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4841 per EA |
|---|---|
| All-time high | $30.6015 (Feb 15, 2017) |
| All-time low | $1.2083 (Jul 22, 2020) |
| Median price | $2.9965 |
| Average price | $7.1049 |
| Largest weekly change | +113.6% (Nov 30, 2016) |
| Weeks tracked | 302 |
| Tracking since | Dec 9, 2015 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-86.5%
Last surveyed Sep 15, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the omeprazole, sodium bicarbonate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Oceanside Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
omeprazole, sodium bicarbonate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of OMEPRAZOLE-BICARB 20-1,100 CAP?
The current National Average Drug Acquisition Cost (NADAC) for OMEPRAZOLE-BICARB 20-1,100 CAP, manufactured by Oceanside Pharmaceuticals, is $1.4841 per EA (NDC 68682010230), effective Sep 15, 2021.
How has the price of OMEPRAZOLE-BICARB 20-1,100 CAP changed over time?
Over the history we have for it, the NADAC for OMEPRAZOLE-BICARB 20-1,100 CAP has declined 86.5%. It has been tracked across 302 weekly CMS publications since Dec 9, 2015.
What are the highest and lowest recorded NADAC prices for OMEPRAZOLE-BICARB 20-1,100 CAP?
Since Dec 9, 2015, the NADAC for OMEPRAZOLE-BICARB 20-1,100 CAP has ranged from a low of $1.2083 (Jul 22, 2020) to a high of $30.6015 (Feb 15, 2017), with a median of $2.9965 per EA.
Are there cheaper alternatives to OMEPRAZOLE-BICARB 20-1,100 CAP?
No other NADAC-published product currently shares the active ingredient and strength of OMEPRAZOLE-BICARB 20-1,100 CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures OMEPRAZOLE-BICARB 20-1,100 CAP?
OMEPRAZOLE-BICARB 20-1,100 CAP (NDC 68682010230) is labeled by Oceanside Pharmaceuticals, and CMS classifies it as a generic product.